Variant NM_000492.4:c.1657C>T
Name | NM_000492.4:c.1657C>T |
Protein name | NP_000483.3:p.(Arg553*) |
Genomic name (hg19) | chr7:g.117227865C>T UCSC |
#Exon/intron | exon 12 |
Legacy Name | R553X |
Class | disease-causing |
Subclass | CF-causing |
WT sequence | TGGAATCACACTGAGTGGAGGTCAA C GAGCAAGAATTTCTTTAGCAAGGTG |
Mutant sequence | TGGAATCACACTGAGTGGAGGTCAA T GAGCAAGAATTTCTTTAGCAAGGTG |
dbSNP rs397508148 |
Not found |
5 individuals carrying this variant are reported in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 81 |
---|---|
Asymptomatic compound heterozygote | 1 |
CF | 56 |
CFTR-RD | 19
|
Fetal bowel anomalies | 2 |
Pending (NBS) | 3 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CF | 3193 | heterozygote | CF-causing - Trans |
CF | 3223 | heterozygote | varying clinical consequence- Undef |
CF | 3228 | heterozygote | varying clinical consequence - Trans |
CF | 3251 | heterozygote | CF-causing - Trans |
CF | 3255 | heterozygote | CF-causing - Trans |
CF | 3169 | heterozygote | CF-causing - Trans |
CF | 3164 | heterozygote | CF-causing - Trans |
CF | 2859 | heterozygote | CF-causing - Trans |
CF | 2961 | heterozygote | CF-causing - Trans |
CF | 3029 | heterozygote | CF-causing - Trans |
CF | 3066 | heterozygote | CF-causing - Trans |
CF | 3123 | heterozygote | CF-causing - Trans |
CF | 3150 | heterozygote | CF-causing - Trans |
CF | 3262 | heterozygote | CF-causing - Trans |
CF | 3297 | heterozygote | CF-causing - Trans |
CF | 3746 | heterozygote | CF-causing- Undef |
CF | 4006 | heterozygote | CF-causing- Undef |
CF | 4063 | heterozygote | CF-causing - Trans |
CF | 4225 | heterozygote | CF-causing- Undef |
CF | 4327 | heterozygote | likely CF - Trans |
CF | 4380 | heterozygote | CF-causing- Undef |
CF | 4440 | heterozygote | CF-causing - Trans |
CF | 4544 | heterozygote | CF-causing- Undef |
CF | 3571 | heterozygote | CF-causing - Trans |
CF | 3485 | heterozygote | CF-causing- Undef |
CF | 3320 | heterozygote | CF-causing - Trans |
CF | 3378 | heterozygote | CF-causing - Trans |
CF | 3408 | heterozygote | CF-causing - Trans |
CF | 3413 | heterozygote | CF-causing - Trans |
CF | 3457 | heterozygote | CF-causing- Undef |
CF | 2836 | heterozygote | CF-causing - Trans |
CF | 2828 | heterozygote | CF-causing - Trans |
CF | 955 | heterozygote | CF-causing - Trans |
CF | 1011 | heterozygote | CF-causing - Trans |
CF | 1031 | heterozygote | CF-causing - Trans |
CF | 1094 | heterozygote | CF-causing- Undef |
CF | 655 | heterozygote | CF-causing- Undef |
CF | 4723 | heterozygote | CF-causing- Undef |
CF | 230 | heterozygote | CF-causing- Undef |
CF | 267 | heterozygote | CF-causing- Undef |
CF | 316 | heterozygote | varying clinical consequence- Undef |
CF | 2179 | heterozygote | CF-causing- Undef |
CF | 2469 | heterozygote | CF-causing- Undef |
CF | 2610 | heterozygote | CF-causing- Undef |
CF | 2635 | heterozygote | likely CFTR-RD- Undef |
CF | 2694 | heterozygote | CF-causing- Undef |
CF | 2719 | heterozygote | CF-causing - Trans |
CF | 2111 | heterozygote | CF-causing- Undef |
CF | 2099 | heterozygote | CF-causing- Undef |
CF | 5510 | heterozygote | CFTR-RD-causing - Trans |
CF | 5511 | heterozygote | CFTR-RD-causing - Trans |
CF | 1740 | heterozygote | CF-causing- Undef |
CF | 1838 | heterozygote | CF-causing- Undef |
CF | 1976 | heterozygote | CF-causing- Undef |
CF | 2001 | heterozygote | CF-causing- Undef |
CF | 62 | heterozygote | CF-causing - Trans |
Other | 3233 | heterozygote | CFTR-RD-causing - Trans |
Other | 3141 | heterozygote | CFTR-RD-causing - Trans |
Other | 2834 | heterozygote | CFTR-RD-causing - Trans |
Other | 5201 | heterozygote | CFTR-RD-causing- Undef |
Other | 1123 | heterozygote | CFTR-RD-causing- Undef |
Other | 4695 | heterozygote | CFTR-RD-causing- Undef |
Fetal bowel anomalies | 3186 | heterozygote | CF-causing - Trans |
Fetal bowel anomalies | 4709 | heterozygote | CF-causing - Trans |
CRS-NP | 4841 | heterozygote | varying clinical consequence- Undef |
CBAVD | 4552 | heterozygote | |
CBAVD | 5945 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 4794 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 4795 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 401 | heterozygote | |
CBAVD | 1434 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1447 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 2742 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 1507 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1875 | heterozygote | CFTR-RD-causing- Undef |
Pending (NBS) | 3042 | heterozygote | varying clinical consequence - Trans |
Pending (NBS) | 5570 | heterozygote | CFTR-RD-causing - Trans |
Pending (NBS) | 516 | heterozygote | varying clinical consequence - Trans |
Pancreatitis | 2586 | heterozygote | varying clinical consequence- Undef |
Bronchiectasis | 3213 | heterozygote | CFTR-RD-causing - Cis varying clinical consequence - Trans |
Asymptomatic compound heterozygote | 4626 | heterozygote | VUS3 - Trans |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|